Schiffman Lab

 

Working to Understand Who Develops Cancer and Why

The Schiffman Lab studies pediatric hereditary cancer syndromes, with a special interest in genetic susceptibility to childhood cancers. Our research investigates molecular changes in childhood cancers, as well as the germline genetic variation that gives rise to childhood tumors. It is our goal to find out who gets cancer and why, so that we can develop ways to better predict, prevent, and treat cancer in the clinic.

Our Approach

All of our studies include the perspective of evolutionary (Darwinian) medicine, with a focus on comparative oncology to identify universal drivers of cancer risk and development. By examining the genetics of cancer in our animal relatives alongside our own, we offer a dynamic and creative approach to translational genomics. Working with collaborators from all over the country and the world, we’re able to study cancer in people, dogs, and elephants. This transdisciplinary approach continues to yield new and exciting results.

Comparative Oncology

Areas of Study

p53 Studies

  • p53 and Li-Fraumeni Syndrome
  • Elephant p53

Ewing Sarcoma

  • What Is Ewing Sarcoma?
  • Genetic Predispositions for Ewing Sarcoma (Project GenESis)
  • The Genetics of Ewing Sarcoma Tumors

Cancer in the Population

News & Blog

4
research
Aug 29, 2018

Having HOPE to fight cancer

September is Childhood Cancer Awareness Month, and Kneaders Bakery and Cafe is encouraging customers to join them in their unique campaign to fight childhood cancer, one delicious cookie at a time!... Read More

Select...
research
Aug 23, 2018

Kneaders Childhood Cancer Awareness

Starting September 12, you can buy these delicious Elephant-shaped sugar cookies, dipped in white chocolate, with sprinkles at any of the 9 Kneaders locations in Colorado. 100% of sales from each cookie sale goes to benefit Dr. Josh Schiffman's Childhood Cancer Research at the Huntsman Cancer Institute.... Read More

Select...
research
Aug 22, 2018

Hyundai Hope On Wheels Presents Intermountain Primary Children's Hospital With $1 Million Hyundai Quantum Grant Award To Support Pediatric Cancer Research

Hyundai Hope On Wheels® 501c3 nonprofit organization celebrates its 20th year in the fight funding pediatric cancer research and will present Dr. Joshua Schiffman of Intermountain Primary Children's Hospital with a $1 million Hyundai Quantum Grant. This institution is one of 4 recipients of this year's award, which is the largest grant category given to support research on pediatric cancers with low survival rates.... Read More

Select...
Huntsman Cancer Institute Researchers Share Expertise at National Cancer Meeting
health-care-trans
Apr 11, 2017

Huntsman Cancer Institute Researchers Share Expertise at National Cancer Meeting

Huntsman Cancer Institute,

More than 20 researchers from Huntsman Cancer Institute (HCI) at the University of Utah made their mark on the American Association of Cancer Research (AACR) Annual Meeting this year. Held in Washington, D.C., the convention drew more than 21,500 cancer researchers from all over the world. Scientists attended sessions on topics from immunotherapy to precision medicine. About 15 researchers from HCI presented posters in the main conference hall, on a wide range of topics. ... Read More

research
Oct 18, 2016

Think Big

In elephants’ cancer-resistant genes, an oncologist sees new hope for people. A few years ago pediatric oncologist Joshua Schiffman ’96 MD’00 learned an astonishing fact. Elephants have an extraordinarily low rate of cancer, despite their enormous size and long lifespan.... Read More

Select...
Mary Beckerle
Joshua Schiffman, MD
Principal Investigator
joshua.schiffman@hci.utah.edu
Cancer Center Bio

Contact Us

For any and all questions, or to find out how you can get involved, please email Schiffman.Research@hci.utah.edu